Home » Posts tagged 'vectorvest grt earnings growth rate' (Page 4)
Tag Archives: vectorvest grt earnings growth rate
Buy Gulf Keystone Petroleum #GKP says VectorVest. The stock currently offers a decent investment proposition to investors with an appetite for risk
Gulf Keystone Petroleum (GKP.L) is a leading independent operator and producer in the Kurdistan Region of Iraq and the operator of the Shaikan field with current production capacity of 40,000 barrels of oil per day. The Kurdistan Region of Iraq segment consists of the Shaikan, Ber Bahr blocks and the Erbil office, which provides support to the operations in Kurdistan. The UK segment provides geological, geophysical, engineering and corporate services to the Company.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On January 22nd 2018, GKP published an operational and corporate update. GKP confirmed a net cash position of $157m as at Jan 19th 2018, and said gross production guidance for 2018 is being set at 27,000-32,000 bopd. The lower range compared to 2017 is due to the need to install downhole pumps in some wells, which are part of the investment programme delayed into 2018. GKP confirmed a strong safety performance in 2017 and into 2018 with no lost-time incidents at the Shaikan field. Operations in the area remain secure, and a plant uptime of 99% in 2017 helped contribute to an average gross production of 35,298 barrels of oil per day, in the middle of GKP’s guidance range of 32,000-38,000 bopd for the year. Subject to resolution of commercials and the Kurdistan Regional Govt continuing regular payment of monthly invoices, GKP intends on investing this year in wells and facilities to expand production capacity to 55,000 bopd. CEO Jón Ferrier said the board are “very pleased with the progress made to date on the commercial and operational matters to implement this and look forward to concluding commercial matters in the near future.“ Group FY results will be announced on Wed 11 April 2018.
Despite GKP’s region of operations and the comparatively uncertain geopolitical picture, the company has over the past few months triggered a series of positive VectorVest metrics that cannot be ignored. In late December 2017, the VectorVest RT (Relative Timing) metric leapt higher, alerting members to a growth opportunity. RT is a fast, smart, accurate indicator of a stock’s price trend, and despite the stock currently trading at year highs of 130p, GKP still logs a current rating of 1.29 on this metric, which is vey good on a scale of 0.00 – 2.00. Other high scoring metrics include a GRT (Earnings Growth Rate) of 30%, which VectorVest considers excellent. The uncertain geopolitical picture previously mentioned weighs on the RS (Relative Safety) metric, where GKP scores a poor rating of 0.82 (scale of 0.00 to 2.00), but despite this, trading at 130p the stock is still considerably undervalued against a current VectorVest valuation of 179p per share.
The chart of GKP.L is shown above over the past nine months. The share in this time has charted a treble bottom pattern and over the last few weeks a rising low. Price support within the rising low on the 12th February 2018 arrived at a previous swing top which was charted last November 2017. This is bullish price action. The share is undervalued with an excellent price appreciation potential (RV) and is on a BUY recommendation.
Summary: GKP is probably one of the most familiar stocks to the investing community, on account of some huge historical share price movements and a somewhat chequered history. Regardless, as a trading and investing instrument, GKP currently offers a decent investment proposition to investors with an appetite for risk. Despite the poor RS (Relative Safety) rating, VectorVest takes the view that GKP offers significant upside given plans to the expand production facility. The very good RT (Relative Timing) rating in the run up to the results warrants a VectorVest buy rating, but investors are advised to run a close stop loss.
Dr David Paul
March 28th 2018
Readers can examine trading opportunities on GKP and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Dr David Paul of VectorVest discusses market timing, #RWA, #TRI, #GLE & #RQIH on Core Finance TV
Dr David Paul of VectorVest discusses market timing, Robert Walters #RWA, Trifast #TRI, Gleeson #GLE & Randall & Quilter #RQIH with Nick ‘Moose’ Batsford on Core Finance TV.
You can examine these trading opportunities and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-week trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here for more info.
Buy Randall & Quilter #RQIH says VectorVest. Company undergoing a transformation through operational streamlining and refocusing into core areas
Bermuda-based Randall & Quilter Investment Holdings (RQIH.L) is a specialist non-life insurance acquirer, service provider and underwriting manager. RQIH generates profits and capital extractions from expert management of legacy non-life insurance acquisitions/reinsurances, including in Lloyds, and generates commission income from its licensed (and rated) carriers in the US and EU/UK, writing niche and profitable programme business, largely on behalf of highly rated reinsurers. RQIH was founded by Ken Randall and Alan Quilter in 1991.
FREE! For free VectorVest analysis on any stock, go to this link here
On January 8th 2018, RQIH announced a board restructure and said it continued to make “excellent progress, with Group simplification proceeding well, and a strong new business pipeline.” On January 15th 2018, RQIH announced the sale of its insurance services and captive management operations to digital solutions provider Davis Group. The proceed of around £18.6m will be used to help finance the group’s growing legacy transaction pipeline, especially in the US and Lloyd’s, and to generate commission income from the use of Accredited and Malta’s direct licenses. Chairman Ken Randall said: “The sale of our insurance services and captive management operations is a significant milestone in the group’s decision to simplify its operations and focus on our core areas of legacy acquisitions and the writing of quality programme business, which is mostly reinsured to highly rated reinsurers.” Separately broker Numis reiterated a buy rating and 195p target for RQIH in Feb 2018.
The sequence of moves to simplify and streamline group operations was flagged at the start of January by several key VectorVest metrics. These include RV (Relative Value) – an indicator of long-term price appreciation potential and where RQIH scores 1.57, which again is excellent on a scale of 0.00 to 2.00. RQIH also scores an excellent GRT (Earnings Growth Rate) of 34%, and while the RS (Relative Safety) metric only registers a fair rating of 0.98 (scale of 0.00 to 2.00), trading at 151p the stock is still considerably undervalued against a current VectorVest valuation of 228p per share.
The chart of RQIH.L is shown below using weekly candles over the past two years using my normal notation. The valuation is shown by the green line study above the price while earnings per share is shown by the blue line study in the window below the price. The share has charted an ascending triangle since November 2016 and looks highly probable to break upwards from this bullish formation soon.
Summary: Hot on the heels of niche finance group STM last week, VectorVest presents yet another sector play. First established in 1991, RQIH is undergoing a transformation through operational streamlining and refocusing into core areas. With a solid long-term track record, broker support and a bullish charting configuration currently playing out, VectorVest believes the stock will continue to push higher and achieve the current 228p price target by Q3 2018.
Dr David Paul
March 20th 2018
Readers can examine trading opportunities on RQIH and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
VectorVest – Adventurous investors should buy STM Group #STM in the run up to full year results.
AIM listed STM Group (STM.L) is a multi jurisdictional financial services group, which specialises in the delivery of a wide range of financial service products to professional intermediaries. The group also undertakes the administration of assets for international clients in relation to retirement, estate and succession planning and wealth structuring. Today, STM has operations in UK, Malta, Jersey, Spain and Gibraltar. The Group is looking to expand through the development of additional products and services that it’s ever more sophisticated clients demand. STM has developed a specialist international pensions division, which specialises in UK SIPPs, Qualifying Recognised Overseas Pension Schemes (QROPS) and Qualifying Non UK Pension Schemes (QNUPS). STM has a Gibraltar Life Insurance Company, STM Life plc, which provides life insurance bonds – wrappers in which a variety of investments, including investment funds, can be held.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On January 24th 2018, STM published a pre-close trading update for the year to 31 Dec 2017, and said it expects to deliver a pre-tax profit of not less than £3.8m (2016: £2.8m). STM said a key component enabling the delivery of record PBT was the International SIPP (ISIPP) product launch, post the March 2017 UK budget announcement. This, along with an annual recurring revenue stream makes up over 70% of STM revenues, giving predictability over the underlying monthly performance. Subsequently on February 24th STM subsidiary STM Malta Ltd announced it had completed the acquisition of Harbour Pensions Ltd. CEO Alan Kentish said investment in the repositioning of STM’s business “brings opportunities in 2018 to improve our profit margins.” Full year results will be published on March 27th 2018.
In January 2018, the VectorVest RT (Relative Timing) metric leapt higher, alerting members to a growth opportunity. RT is a fast, smart, accurate indicator of a stock’s price trend, and despite the stock rocketing from 35p to 54p over a few days, STM still logs a current rating of 1.48 on this metric, which is excellent on a scale of 0.00 – 2.00. Other high scoring metrics include a GRT (Earnings Growth Rate) of 21%, which VectorVest considers excellent. Cautious investors may want to looks elsewhere, as STM currently scores a lowly 0.84 on the RS (Relative Safety) metric (scale of 0.00 to 2.00), but despite this, trading at 50p the stock is still considerably undervalued against a current VectorVest valuation of 65.5p per share.
A weekly candlestick chart of STM.L is shown above over the last three years. The blue line study in the window below price is Earnings Per Share (EPS) which has grown significantly over the period. Since August 2016 the share has charted a treble bottom formation which is positive for the share. STM.L is on a BUY recomdendation on VectorVest.
Summary: Niche finance groups are regularly flagged as buying opportunities across the VectorVest stock analysis and portfolio management system and STM is no exception. This diversified financial services operator continues to develop and expand its portfolio of services for a sophisticated client base, and despite some challenges during 2017, management have not only delivered a record PBT result, but see further opportunities to grow profit margins in the current year. As such, for adventurous investors VectorVest rates the stock as a buy in the run up to FY results at the end of March 2018
Dr David Paul
March 14th 2018
Readers can examine trading opportunities on STM and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy Evraz #EVR says VectorVest. The turnaround over the past year has been nothing short of spectacular.
Evraz plc (EVR.L) is a steel, mining and vanadium business with operations in the Russian Federation, Ukraine, the United States, Canada, the Czech Republic, Italy, Kazakhstan and South Africa. The Company’s principal activities include manufacturing steel and steel products; iron ore mining and enrichment; coal mining; manufacturing vanadium products, and trading operations and logistics. Its segments include Steel; Steel, North America; Coal, and Other Operations. The Steel segment is engaged in the production of steel and related products at all mills except for those located in North America. The Steel, North America segment is engaged in the production of steel and related products in the United States and Canada. The Coal segment includes coal mining and enrichment. Other Operations include energy-generating companies, shipping and railway transportation companies.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On March 1st 2018, EVR published FY results for the year ended 31 Dec 2017, which revealed strong free cash flow of $1.32bn (FY2016: $659m), with consolidated EBITDA of $2.62bn, up 70.2% from $1.54bn in FY2016. Strong market conditions and numerous improvement initiatives drove the EBITDA margin from 20.0% to 24.2%. EVR reported a further reduction in net debt to $4bn (FY2016: $4.8bn), with an overall net profit of $759m (FY2016: $188m loss). As a result a second interim dividend of $429.6m ($0.30 per share) has been declared, reflecting the Board’s confidence in the Group’s financial position and outlook. Looking forward, CEO Alexander Frolov said: “As we progress in 2018, we remain committed to our vision and believe that our pipeline of investment projects and operational efforts, combined with favourable market conditions will enable us to generate strong financial results and benefit all our stakeholders.”
As with so many stocks appearing across VectorVest metrics, the upsurge in production at EVR was identified on the RT (Relative Timing) metric as far back as June last year. RT is a fast, smart, accurate indicator of a stock’s price trend, and despite the near doubling in share price since June last year, EVR still logs a current rating of 1.75 on this metric, which is excellent on a scale of 0.00 – 2.00. Other high scoring metrics include RV (Relative Value) – an indicator of long-term price appreciation potential. Here EVR scores 1.62, which again is excellent on a scale of 0.00 to 2.00. EVR also scores an excellent GRT (Earnings Growth Rate) of 38%, and while the RS (Relative Safety) metric only registers a fair rating of 0.98 (scale of 0.00 to 2.00), trading at 437p the stock is still considerably undervalued against a current VectorVest valuation of 670p per share.
The chart of EVR.L is shown below in my normal format. The share is on a Buy recommendation on VectorVest and trending strongly upwards. The blue line study shows Earnings per Share (EPS) which has trebled over the last year. This is the engine that’s driving the share price upwards.
Summary: This steel and metals mining & production giant has enjoyed varied fortunes over the past 5 years, while debt concerns and a dip in steel prices in 2015 saw EVR test lows of just 60p. The turnaround over the past year has been nothing short of spectacular, and while the volatile nature of the stock warrants a low RS (Relative Safety) rating, the special dividend and bullish outlook announced by the board ensures a medium term buy rating and thumbs up from VectorVest. Buy.
Dr David Paul
March 6th 2018
Readers can examine trading opportunities on EVR and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy Urals Energy #UEN says VectorVest. Fundamentals & relative timing add up to a highly attractive oil sector play.
AIM listed Urals Energy (UEN.L) is an independent oil company with its operating assets located in Russia. UEN is primarily engaged in oil and gas exploration and production in the Russian Federation and processing of crude oil for distribution on both Russian and international markets. The Company’s exploration and production operations are on the Kolguyev Island based in Timan Pechora and on Sakhalin Island. The Company’s ZAO Petrosakh develops the Okruzhnoye field on the Eastern coast of Sakhalin Island. The Company’s ZAO Arcticneft develops and operates the Peschanoozerskoye field on Kolguyev Island in the Barents Sea. The Company is producing on average approximately two thousand barrels of oil per day from Petrosakh and Arcticneft with 100% of production being refined in Petrosakh and 100% being exported in Arcticneft.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On December 21st 2017, UEN published an update on its reserves, and on progress in drilling at the South Dagi licence on Sakhalin Island. UEN said it had spudded its first exploration well at South Dagi, adding that any oil production from the new wells will be transported by road tanker to the Company’s refinery at Petrosakh, a distance of 400 kms, which will increase the utilisation rate of the Company’s refinery. No additional investment will be needed to process both the heavy and light oils expected from South Dagi.
As announced on 15 June 2016, the Russian State Registered reserves of C1 plus C2, equivalent to 2P (proven and probable), on the South Dagi license area are 17.7m barrels, with C3 or possible reserves of 9.0m barrels. At shallow levels, the oil is relatively heavy (23.5 – 25.5°API), with light oil (36.5 – 37.5°API), similar to the oil at the Company’s Petrosakh operation, at lower horizons. As part of the Competent Person’s Report UEN said that Blackwatch Petroleum Services has estimated the mean total 2P reserves at South Dagi to be approximately 23.5m barrels of oil across six reservoirs. UEN Chairman Andrew Shrager said the spudding of the first well at South Dagi “is extremely important as it opens the possibility to increase the production at our Petrosakh refinery, thus continuing to take advantage of having the only refinery on Sakhalin Island.“
The potential earnings growth from UEN’s E&P activities had been identified by VectorVest stock analysis metrics as far back as August 2017, long before the January spike in the share price. Despite the sharp rise, UEN continues to score highly across all key VectorVest metrics – the GRT (Earnings Growth Rate) metric retains a forecasted GRT of 36%, which VectorVest considers to be excellent. Although the RS (Relative Safety) metric at 0.86 (scale of 0.00 to 2.00) is low, UEN scores an excellent RV (Relative Value) rating of 1.51 on the same scale. VectorVest now attributes an overall value of 166p for UEN, meaning that at today’s 122p the stock is undervalued. Overall, UEN will be most suitable for investors who can manage risk and understand position sizing techniques.
The chart of UEN.L is shown above in my normal format. The share rose strongly in price during January 2018 and subsequently retraced to test the previous resistance that was in place since October 2017. Presently the share is on a Buy recommendation on VectorVest and pushing on a 26 week high. Technical Analysts reading will note the large “cup and handle” formation that the share has charted over the last 9 months. This is a bullish pattern and with a close above the 26 week high, the probabilities favour a move higher.
Summary: Although the UEN share price drifted lower for the majority of 2017, the developments at the South Dagi oil prospect has seen shares double in value in a very short space of time. As I would expect with oil E&P stocks, the low VectorVest RS rating may see cautious investors look elsewhere, but nonetheless, UEN fundamentals, earnings growth and current valuation gap all add up to a highly attractive oil sector play at this moment in time. Buy.
Dr David Paul
February 27th 2018
Readers can examine trading opportunities on UEN and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy Cambian Group #CMBN says VectorVest. The commercial backdrop offers considerable investment potential.
Cambian Group (CMBN.L) is one of the UK’s leading children’s specialist education and behavioural health service providers. Founded in 2004, it has grown to become a significant partner to the UK public sector. The Group’s services have a specific focus on children who present high severity needs with challenging behaviours and complex care requirements. CMBN looks after 2,000 children and employs over 4,300 people across a portfolio of 224 residential facilities, specialist schools and fostering offices located in England and Wales.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On January 30th 2018, CMBN published a trading update, for the year ending December 31st 2017. Underlying trading for the year was in line with Board expectations, while net cash at year-end was approximately £82m ahead of Board expectations. As a result CMBN declared a further special dividend of 8.2 pence per share, equating to a further £15m return of capital to shareholders following the £50m return of capital completed in Sept 2017. CEO Saleem Asaria commented; “After a period of significant change at Cambian we are pleased to have the opportunity to outline the medium and long-term value creation opportunities that our business presents to our investors. Cambian has the potential to add capacity and create growth in the coming years and in so doing build a platform across the UK that offers the highest standards of integrated care to our children. We believe we can achieve life-changing results for the children who are entrusted to us and at the same time continue to create value for our investors.”
The solid earnings growth and strong cash position had been identified by VectorVest stock analysis metrics as far back as November 2017 when the share was revalued upwards. At present the stock continues to score highly across all key VectorVest metrics. The GRT (Earnings Growth Rate) metric logs a forecasted GRT of 27%, which VectorVest considers to be excellent. Added to this, CMBN scores an excellent RT (Relative Timing) rating of 1.43, (scale of 0.00 to 2.00). VectorVest now values CMBN at 239p, marking the stock out as undervalued at the current 198p. However the safety of the Earnings as measured by the VectorVest metric RS is low which means the opportunity in Cambian is only suitable for those investors who can manage risk and understand position sizing techniques.
The chart of CMBN is shown above where the green line study plots the VectorVest valuation of the share which has risen strongly over the past 6 months. Technically the share has broken upwards from an inverted “head and shoulders” pattern which is a bullish sign. The technical target from the reversal “head and shoulders” pattern is similar to the VectorVest valuation.
Summary: An investment into CMBN also provides investors with an opportunity to invest into children’s specialist education and behavioural health – a worthwhile endeavour by any standards. Added to this, the CMBN board demonstrate prudent financial management, which in the words of the CEO offer “medium and long-term value creation opportunities. As such, VectorVest believes the commercial backdrop offers investors considerable investment potential. Buy.
Dr David Paul
February 21st 2018
Readers can examine trading opportunities on CMBN and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Buy KAZ Minerals #KAZ says VectorVest. Current valuation gap adds up to a compelling investment opportunity.
UK-based KAZ Minerals Plc (KAZ.L) is a high growth copper company focused on large scale, low cost, open pit mining in Kazakhstan. It operates the Bozshakol and Aktogay open pit copper mines in the Pavlodar and East Region of Kazakhstan, three underground mines and associated concentrators in the East Region of Kazakhstan and the Bozymchak copper-gold mine in Kyrgyzstan. In 2017, total copper production was 259 kt with by-products of 58 kt of zinc in concentrate, 179 koz of gold and 3,506 koz of silver. KAZ is listed on the London Stock Exchange, the Kazakhstan Stock Exchange and the Hong Kong Stock Exchange and employs around 13,000 people, principally in Kazakhstan.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On January 25th 2018 KAZ announced that FY copper production had increased by 80% to 259 kt, at top of February 2017 FY guidance (225-260 kt) and in line with updated range (250-270 kt). KAZ said that FY gold production of 179 koz was also at the upper end of guidance range (160-180 koz). CEO Andrew Southam added that the performance of the two recently commissioned mines at Bozshakol and Aktogay “has delivered an 80% increase in annual copper output into a tightening market and gold production at the top of our guidance range.”
The pace of production growth at KAZ has been well documented by VectorVest metrics over the past year, plus I have discussed the investment opportunity on numerous Core Finance interviews. The GRT (Earnings Growth Rate) metric flagged up the potential in a year ago, when the shares were trading around 440p. Now at trading at 788p, KAZ still retains a forecasted GRT of 42%, which VectorVest considers to be excellent. Traders should note that the RS (Relative Safety) metric records a fair rating of 0.93 on a scale of 0.00 to 2.00, meaning the stock is not without risk, but regardless the stock remains considerably undervalued at 788p against a current VectorVest valuation of 1516p per share.
The chart of KAZ.L is shown above in my normal format. The blue line study in the window below the price shows earnings per share (EPS) growing strongly over the last year. KAZ.L retreated with the recent worldwide selloff. Fibonacci analysts will notice that both the share and the copper price have found support at an important FIB level.
Summary: VectorVest have always maintained the view that mining and resource stocks are for more adventurous investors, but in the case of KAZ the sheer size of the valuation gap (788p-1516p) marks the stock out as a compelling buy. This argument is also backed by steadily improving commodity prices, fuelled as ever by the relentless demand from emerging economies.
Dr David Paul
February 13th 2018
Readers can examine trading opportunities on KAZ and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Reiterate Buy Eland Oil & Gas #ELA say VectorVest. The timing is once again right to buy into this fast growing oil and gas company
UK-based Eland Oil & Gas PLC (ELA.L) is an independent oil and gas company focused on building and developing a portfolio of producing upstream oil and gas assets in West Africa, primarily in the Niger Delta region of Nigeria. Its core assets are the OML 40 license and the Ubima field, both onshore Nigeria. The OML 40 license is situated within the Niger Delta, approximately 75 kilometers northwest of Warri and covers an area of over 500 square kilometers. The environment in OML 40 consists of shoreline and coastal mangrove swamps. The OML 40 license includes Opuama, Gbetiokun, Polobo, Abiala and Amobe. Primary gross contingent resources in the OML 40 license amounts to 41.2 million barrels (mmbbl). The Ubima Field covers an area of approximately 70 square kilometers and is located onshore in the northern part of Rivers State.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On January 17th 2018, Eland reported that its joint-venture subsidiary Elcrest Exploration and Production Nigeria Ltd had successfully drilled and completed the Opuama-8 well. The Opuama-8 well has been handed over to the Opuama field production team and the well will flow test into the production facilities and on to export. Production performance from the Opuama field is strong, with gross production from Opuama-1, -3 and -7 wells being approximately 18,000bopd. CEO George Maxwell, commented: “We are pleased with the successful drilling and completion of the Opuama-8 well and we look forward to confirming stabilised production rates in due course. The success of Opuama-8 will result in increased production and cash generation from OML 40. Our drilling programme will continue beyond Opuama-9, where our continued investment will further enhance both production and cash flow levels.” At the interim results on September 26th 2018 George Maxwell said, “The outlook for the remainder of 2017 and beyond is very positive”.
VectorVest first published an article on ELA in May 2017 when the stock traded at 65p. The Opuama development took a while to move to production, but the stock recently hit and passed our May target of 81p. Today, the stock continues to score highly across all key VectorVest metrics, with the VST-Vector, (master indicator for ranking every stock in the VectorVest database) logging ELA today at 1.35, which is very good on a scale of 0.00 to 2.00. And with an excellent RT (Relative Timing) rating of 1.46, (scale of 0.00 to 2.00), VectorVest now values the stock at 108p, offering significant upside from the current 85p.
The chart of ELA.L is shown below with the green line study above the price reflecting the VectorVest calculated valuation of the company. The share is trending higher and is on a Buy recommendation on the VectorVest program. Earnings per share is shown by the blue line study in the window below the price and is growing strongly over the past year.
Summary: ELA is another growth company that highlights the solid track record of the VectorVest stock analysis and portfolio management system. With the Opuama field resulting in increased production and cash generation, the timing is right to once again buy into this quality oil and gas play.
David Paul
February 6th 2018
Readers can examine trading opportunities on ELA and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Sopheon #SPE has risen 8X since first being flagged up by VectorVest. We still rate the stock as a buy!
Sopheon partners with customers to provide complete enterprise solutions
There is lots still to come in this excellent growth prospect.
Woking-based Sopheon (SPE.L) is engaged in the provision of software and services in the product lifecycle management (PLM) market. The Company operates in two segments: N America and Europe. Its Accolade solution provides integrated support for innovation planning, roadmapping, idea and concept development, process, project, portfolio, resource and in-market management. Its offerings include alignment of long-term innovation plans with market requirements, industry regulations, and supply chain capabilities; generation and development of ideas and concepts to fill gaps relevant to achieving strategic initiatives; process and project management that tracks and enables decision making, focused on evaluating projects associated with innovation initiatives, and data management, analytics and integrity tools. Subsidiaries include Sopheon Corporation, Alignent Software, Inc., Sopheon NV, Sopheon UK Ltd and Sopheon GmbH.
Examine this trading opportunity and a host of other similar stocks. A single payment of £5.95 gives access to the VectorVest Risk Free 30-day trial. More here
On Monday 29th Jan 2018, SPE updated on trading for the year ended 31 Dec 2017. The strong trading in the closing weeks of the year resulted in two substantial Accolade deals signed, one in the USA and one in Germany, each with a multinational enterprise that is an undisputed leader in its field. Consequently, the board expects that reported revenues for the year will be over $28m, up from $23m in 2016, and comfortably ahead of current market expectations. EBITDA and PTP will also be significantly ahead of current market expectations, with a year-end net cash position expected at $9.5m (2016: $4.2m). Looking forward overall revenue visibility for 2018 already stands at $18m, vs. $13m at this time last year. FY results will be announced on March 22nd 2018.
What VectorVest sees in Sopheon
VectorVest first identified SPE as a quality investment opportunity as far back as 2016 when the stock traded at around 70p. A spectacular 8-fold return since then sees SPE trading at 560p today, but despite this the VectorVest stock analysis and portfolio management system indicates that there is considerably more upside to come. Among a range of metrics highlighting value, the Earnings Growth Rate (GRT), (which reflects a company’s one to three year forecasted earnings growth rate in percent per year) sees SPE score 17%, which VectorVest considers to be very good. The VST-Vector metric (VST) and the master indicator for ranking every stock in the VectorVest database, logs a rating of 1.28, again very good on a scale of 0.00 to 2.00. Finally, despite the meteoric rise in the stock price, the VectorVest Value metric attributes a current value of 646p per share to SPE, meaning the company is still undervalued at the current 560p.
The chart of SPE.L is shown above over the last two years of trading. The green line study above the price reflects the VectorVest valuation while the blue line study shows the growth of Earnings per share (EPS) over the period. The share is on a Buy recomedendation on VectorVest after recently gapping through a 52 week high. This is regarded by technical analysts as a bullish sign. Also of interest to technical analysts is the “pennant” chart pattern from which the share broke on the 4th January 2018. The target from this breakout by conventional charting techniques is approximately 700p.
Can Sopheon keep going up?
Some investors may be put off by investing into SPE at such heady levels given the 8-fold increase in value. But the cash generative nature of this well-managed software business is precisely why it’s stock has historically delivered such strong returns for shareholders to date, and those same qualities exist in abundance at SPE today. VectorVest believes an ‘if it isn’t broke, why try to fix it’ approach is warranted for SPE, with every reason to keep buying the stock for continuing growth.
Dr David Paul
January 31 2018
Readers can examine trading opportunities on SPE and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 30-day trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
VectorVest Unisearch
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.